Accelerate Diagnostics, Inc

Baird Financial Group, Inc.

Report date

6/30/2023

Quarter

2023 Q2

Filed

8/11/2023

Shares

30,029

Value ($000)

24

Weight

0.0%

2019 Q4 - 2023 Q2 (15 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q2	8/11/2023	24	0.0%	30,029	6/30/2023
2023 Q1	5/15/2023	21	0.0%	30,029	3/31/2023
2022 Q4	2/13/2023	21	0.0%	30,029	12/31/2022
2022 Q3	11/15/2022	46	0.0%	30,029	9/30/2022
2022 Q2	8/8/2022	30	0.0%	30,029	6/30/2022
2022 Q1	5/13/2022	2,508	0.0%	1,741,547	3/31/2022
2021 Q4	2/9/2022	7,872	0.0%	1,508,069	12/31/2021
2021 Q3	11/12/2021	6,459	0.0%	1,107,900	9/30/2021
2021 Q2	8/11/2021	8,350	0.0%	1,035,951	6/30/2021
2021 Q1	5/13/2021	8,193	0.0%	984,737	3/31/2021
2020 Q4	2/11/2021	7,409	0.0%	977,385	12/31/2020
2020 Q3	11/12/2020	10,142	0.0%	951,385	9/30/2020
2020 Q2	10/22/2020	14,626	0.1%	964,744	6/30/2020
2020 Q1	5/14/2020	4,506	0.0%	540,936	3/31/2020
2019 Q4	2/14/2020	7,551	0.0%	446,803	12/31/2019